Biomedical Innovation Centers Grants

Biomedical Innovation Centers Grants is sponsored by Empire State Development (NY State). Supports NY-based biotech startups developing medical devices, including implantable drug delivery systems, to advance commercialization and clinical translation. This program should be reviewed carefully against your organization's mission, staffing capacity, timeline, and compliance readiness before you commit resources to a full application. Strong submissions usually translate sponsor priorities into concrete objectives, clear implementation milestones, and measurable public benefit.

For planning purposes, treat March 31, 2026 as your working submission target unless the sponsor publishes an updated notice. A competitive project plan should include a documented need statement, implementation approach, evaluation framework, risk controls, and a realistic budget narrative. Even when a grant allows broad program design, reviewers still expect credible evidence that the proposed work can be executed within the grant period and with appropriate accountability.

Current published award information indicates $100,000 - $500,000 Organizations should verify the final funding range, matching requirements, and allowability rules directly in the official opportunity materials before preparing a budget. Finance and program teams should align early so direct costs, indirect costs, staffing assumptions, procurement timelines, and reporting obligations all remain consistent throughout drafting and post-award administration.

Eligibility guidance for this opportunity is: Small businesses and startups in New York State If your organization has partnerships, subrecipients, or collaborators, define responsibilities and compliance ownership before submission. Reviewers often look for implementation credibility, so letters of commitment, prior performance evidence, and a clear governance model can materially strengthen the application narrative and reduce concerns about delivery risk.

A practical approach is to begin with a focused readiness review, then build a workback schedule from the sponsor deadline. Confirm required attachments, registration dependencies, and internal approval checkpoints early. This reduces last-minute issues and improves submission quality. For the most accurate requirements, always rely on the official notice and primary source links associated with Biomedical Innovation Centers Grants.

NYS Matching Grants Leverage Program | Center for Biotechnology – Stony Brook University Whether your personal interests are in supporting innovation , bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy , the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.

Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients. Give to the Center for Biotechnology online through the Stony Brook Foundation.

Contributions can be made to our Fund for Excellence . More information about donating through the Stony Brook Foundation can be found here .

Center for Biotechnology – Stony Brook University NYS Matching Grants Leverage Program NYSTAR reviews and coordinates requests for New York State matching grants and support letters to strengthen applicants’ proposals to federal agencies, foundations, and other grant-making organizations.

The purpose of this program is to attract more federal R&D funding to support technology development and commercialization efforts in New York State. While funding is available, NYSTAR will accept applications monthly with a submission deadline of the 20th. The first Round will have a deadline for application submission of January 20, 2022.

Learn more and apply here: https://esd. ny.

gov/matching-grants-leverage-program [category__not_in] => Array [post_parent__in] => Array [post_parent__not_in] => Array [author__not_in] => Array [search_columns] => Array [update_post_term_cache] => 1 [update_menu_item_cache] => [lazy_load_term_meta] => 1 [update_post_meta_cache] => 1 [comments_per_page] => 50 [tax_query] => WP_Tax_Query Object [table_aliases:protected] => Array [primary_table] => wp_posts [primary_id_column] => ID [meta_query] => WP_Meta_Query Object [table_aliases:protected] => Array [clauses:protected] => Array [has_or_relation:protected] => [request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.

ID WHERE 1=1 AND wp_posts. post_type = 'post' AND ((wp_posts. post_status = 'publish')) [post_date] => 2025-07-17 10:27:09 [post_date_gmt] => 2025-07-17 14:27:09 The Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth.

The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development 's Division of Science, Technology and Innovation (NYSTAR) , a recognition that comes with $1 million in annual funding over the next ten years.

The $10 million commitment underscores the CFB’s leadership in accelerating life science innovation, supporting early-stage technology development, and fueling economic growth through start-up formation and industry partnerships. “The Center for Biotechnology has served as a critical bridge between academic research and commercial success,” said Dr. Clinton Rubin, Director of the Center for Biotechnology.

“This re-designation ensures we can continue to expand our impact, helping innovators bring breakthrough technology to market and strengthening New York’s position as a leader in the bioscience industry. ” Empire State Development President, CEO and Commissioner Hope Knight said, “NYSTAR’s Centers for Advanced Technology are vital to our strategic efforts to grow New York’s economy and the state’s greater innovation ecosystem.

By investing in the industries of tomorrow, New Yorkers benefit today through dynamic partnerships that help to create new jobs, generate more revenues, and encourage more companies to establish a footprint in communities all throughout the state. ” The Center for Biotechnology is located on the campus of Stony Brook University (SBU), the flagship research institution within the prestigious State University of New York (SUNY) system.

Stony Brook University is recognized as a national and global leader in life sciences research, biomedical innovation, and clinical care. Situated on Long Island, New York, Stony Brook has built a formidable reputation as a hub for cutting-edge scientific discovery and translational medicine.

The Center for Biotechnology builds upon these strengths by providing cutting-edge programming and competitive financial support to advance biomedical innovation and emerging company growth. “We are excited to build upon the successful foundation of strong entrepreneurial networks, infrastructure, and programming that we have built over the last four decades” said Dr. Diane Fabel, Chief Operating Officer at the Center for Biotechnology.

“The impacts we have had during our last designation period include over $1B in total economic impact with more than 1000 jobs created, and driving more than $315M in follow-on funding. We are excited to see those numbers continue to grow when we celebrate fifty years of hard work at the end of this redesignation period”.

As part of the New York State CAT program, the CFB will continue to work with emerging and established companies across the state to de-risk early-stage technologies, advance both technology and company value, foster public-private collaboration, and provide critical infrastructure for the region’s growing life science ecosystem.

Additionally, the CFB team will continue its efforts to develop a life sciences workforce to support the region's bio-innovation economy with a specific emphasis on sectors deemed important to the NYS economy. Dowload the full press release here .

[post_title] => Center for Biotechnology Announces Redesignation as New York State Center for Advanced Technology [post_name] => redesignation2025 [post_modified] => 2025-07-21 14:51:44 [post_modified_gmt] => 2025-07-21 18:51:44 [post_content_filtered] => [guid] => https://centerforbiotechnology. org/?

p=4906 [post_date] => 2024-10-24 10:45:00 [post_date_gmt] => 2024-10-24 14:45:00 Governor Kathy Hochul has unveiled plans for New York BioGenesis Park, a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub in Nassau County, Long Island. To be developed by The Albanese Organization, Inc.

, this state-of-the-art facility would catalyze CGT research, development, clinical manufacturing, and commercialization across New York State. With a historic $150 million state investment—the largest nationwide for a cell and gene therapy hub—NYBGP would accelerate the delivery of new therapies from lab to patient in New York's diverse communities.

This transformative hub aims to establish New York as the leading global destination for CGT innovation, driving economic growth, attracting top talent, and revolutionizing patient care statewide and beyond. The Center for Biotechnology is thrilled to be counted as a partner in this effort, and is looking forward to working with our colleagues in the initiative to help catalyze and accelerate life-changing therapies.

New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization. At full build-out, the 700,000-square-foot park would create an end-to-end Cell and Gene Therapy innovation and supply center, featuring interconnected areas for public engagement, research, manufacturing, and collaboration.

A cornerstone of New York BioGenesis Park is its incubator, supported by a $50 million investment from ESD's Long Island Investment Fund. This facility will empower early-stage therapeutic developers by offering state-of-the-art wet lab space, shared equipment, office space, and other essential resources.

This nurturing environment will provide Cell and Gene Therapy companies with access to specialized equipment, mentoring, and stage-appropriate financial guidance. As a critical component of New York BioGenesis Park, the incubator is poised to catalyze the growth of promising Cell and Gene Therapy companies by providing them with resources and support, unlocking their potential for innovation and success.

New York BioGenesis Park would foster strong ties with academic and medical institutions throughout New York, creating a robust ecosystem for Cell and Gene Therapy innovation.

Collaborating with the Empire State Cellular Therapy Consortium and world-class institutions like Cold Spring Harbor Laboratory, the Feinstein Institutes, Northwell Health, Roswell Park, Stony Brook University, Weill Cornell, Columbia University and others around the state, New York BioGenesis Park would enhance research synergies and accelerate medical breakthroughs.

This ecosystem would bring together experts in advanced Cell and Gene Therapy therapies, offering specialized facilities, services, and resources to both tenants and collaborating institutions.

By facilitating cutting-edge science, innovative technology development and novel approaches to clinical trials, New York BioGenesis Park would ensure New York's institutions remain globally competitive in groundbreaking Cell and Gene Therapy research and commercialization. Read the press release of Governor Hochul's announcement here: https://www. governor.

ny. gov/news/governor-hochul-launches-next-phase-long-islands-nation-leading-cell-and-gene-therapy [post_title] => Long Island to be location for Nation-Leading Cell and Gene Therapy Innovation Hub: New York BioGenesis Park.

[post_name] => long-island-to-be-location-for-nation-leading-cell-and-gene-therapy-innovation-hub-new-york-biogenesis-park [post_modified] => 2025-02-26 16:35:20 [post_modified_gmt] => 2025-02-26 21:35:20 [post_content_filtered] => [guid] => https://centerforbiotechnology. org/?

p=4488 [post_date] => 2023-07-10 12:52:21 [post_date_gmt] => 2023-07-10 16:52:21 The Life Sciences Summit 2023 is returning to New York City - In Person - on October 11th at the Alexandria Center for Life Science. Save the date to join us in the fall and visit lifesciencessummit. org for program and registration updates.

[post_title] => Save the Date! Life Sciences Summit 2023 - October 11 [comment_status] => closed [post_name] => save-the-date-life-sciences-summit-2023-october-11 [post_modified] => 2024-12-03 12:27:34 [post_modified_gmt] => 2024-12-03 17:27:34 [post_content_filtered] => [guid] => https://centerforbiotechnology. org/?

p=4252 [post_date] => 2017-12-05 15:50:11 [post_date_gmt] => 2017-12-05 15:50:11 [post_content] => The L’Oréal USA For Women in Science fellowship program honors female scientists at a critical stage in their careers with grants of $60,000 each. Since 2003, we’ve awarded 70 postdoctoral women scientists over $3. 5 million in grants.

L’Oréal USA For Women in Science fellowship program is seeking five exceptional female scientists looking to advance their research and serve as role models for the next generation of girls in STEM. Applications for the 2018 L’Oréal USA For Women in Science program are now open and are due by February 2, 2018.

Candidates are selected from a variety of fields including the life and physical/material sciences, technology (including computer science), engineering, and mathematics. Candidates must have completed their PhD and have started in their postdoctoral position by the application deadline. The application and more information about the L’Oréal USA For Women in Science program can be found at www.

lorealusa. com/forwomeninscience. [post_title] => L’Oréal USA For Women in Science Fellowship Program [post_name] => loreal-usa-for-women-in-science-fellowship-program [post_modified] => 2018-01-23 14:38:40 [post_modified_gmt] => 2018-01-23 14:38:40 [post_content_filtered] => [guid] => http://centerforbiotechnology.

org/? p=2894 [post_date] => 2020-10-16 14:51:06 [post_date_gmt] => 2020-10-16 14:51:06 Applications for the Center for Biotechnology's Fundamentals of the Bioscience Industry Program are open!

This innovative, one semester, evening program provides participants with the skills and knowledge they need to transition out of the academic lab into a professional position in the bioscience industry and an overall introduction to the technology commercialization process. The program is taught by industry professionals through lectures and interactive team projects.

Students gain first-hand experience in the development of commercialization strategies around real intellectual property and business issues. This experiential learning process will shed light onto the expanded number of business roles to which scientific skills can be applied.

Created by the Center for Biotechnology , this program is targeted towards graduate students and postdocs seeking to facilitate commercial activities within their academic labs or enhance their knowledge of the commercial sector in order to transition into non-academic careers. To learn more about the program and its opportunities visit: www. fobip.

org . 2021 PROGRAM EARLY APPLICATION DEADLINE – FRIDAY, OCTOBER 23 2020 [post_title] => Fundamentals of the Bioscience Industry Program - Application Open! [post_name] => fundamentals-of-the-bioscience-industry-program-application-open [post_modified] => 2021-04-07 20:05:05 [post_modified_gmt] => 2021-04-07 20:05:05 [post_content_filtered] => [guid] => https://centerforbiotechnology.

org/? p=3642 [post_date] => 2025-07-17 10:27:09 [post_date_gmt] => 2025-07-17 14:27:09 The Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth.

The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development 's Division of Science, Technology and Innovation (NYSTAR) , a recognition that comes with $1 million in annual funding over the next ten years.

The $10 million commitment underscores the CFB’s leadership in accelerating life science innovation, supporting early-stage technology development, and fueling economic growth through start-up formation and industry partnerships. “The Center for Biotechnology has served as a critical bridge between academic research and commercial success,” said Dr. Clinton Rubin, Director of the Center for Biotechnology.

“This re-designation ensures we can continue to expand our impact, helping innovators bring breakthrough technology to market and strengthening New York’s position as a leader in the bioscience industry. ” Empire State Development President, CEO and Commissioner Hope Knight said, “NYSTAR’s Centers for Advanced Technology are vital to our strategic efforts to grow New York’s economy and the state’s greater innovation ecosystem.

By investing in the industries of tomorrow, New Yorkers benefit today through dynamic partnerships that help to create new jobs, generate more revenues, and encourage more companies to establish a footprint in communities all throughout the state. ” The Center for Biotechnology is located on the campus of Stony Brook University (SBU), the flagship research institution within the prestigious State University of New York (SUNY) system.

Stony Brook University is recognized as a national and global leader in life sciences research, biomedical innovation, and clinical care. Situated on Long Island, New York, Stony Brook has built a formidable reputation as a hub for cutting-edge scientific discovery and translational medicine.

The Center for Biotechnology builds upon these strengths by providing cutting-edge programming and competitive financial support to advance biomedical innovation and emerging company growth. “We are excited to build upon the successful foundation of strong entrepreneurial networks, infrastructure, and programming that we have built over the last four decades” said Dr. Diane Fabel, Chief Operating Officer at the Center for Biotechnology.

“The impacts we have had during our last designation period include over $1B in total economic impact with more than 1000 jobs created, and driving more than $315M in follow-on funding. We are excited to see those numbers continue to grow when we celebrate fifty years of hard work at the end of this redesignation period”.

As part of the New York State CAT program, the CFB will continue to work with emerging and established companies across the state to de-risk early-stage technologies, advance both technology and company value, foster public-private collaboration, and provide critical infrastructure for the region’s growing life science ecosystem.

Additionally, the CFB team will continue its efforts to develop a life sciences workforce to support the region's bio-innovation economy with a specific emphasis on sectors deemed important to the NYS economy. Dowload the full press release here .

[post_title] => Center for Biotechnology Announces Redesignation as New York State Center for Advanced Technology [post_name] => redesignation2025 [post_modified] => 2025-07-21 14:51:44 [post_modified_gmt] => 2025-07-21 18:51:44 [post_content_filtered] => [guid] => https://centerforbiotechnology. org/?

p=4906 [max_num_comment_pages] => 0 [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array [1] => query_vars_changed [compat_methods:WP_Query:private] => Array [query_cache_key:WP_Query:private] => Center for Biotechnology Announces Redesignation as New York State Center for Advanced Technology Long Island to be location for Nation-Leading Cell and Gene Therapy Innovation Hub: New York BioGenesis Park.

Save the Date! Life Sciences Summit 2023 – October 11 L’Oréal USA For Women in Science Fellowship Program Fundamentals of the Bioscience Industry Program – Application Open! This entry was posted in Uncategorized by Kate Hutchinson .

Bookmark the permalink . Bioengineering Building, 2nd Floor Stony Brook, NY 11794-5280 Fax: 631. 632.

8577 Contact Us Infrastructure Development Management Team & Advisory Board Long Island Bioscience Hub Long Island BioMentor Initiative